Investors

Date	Name	Title	Type	Shares Traded	Price Range
Feb 16, 2012	mccorkle douglas s	Officer	Sell	5,353	107.50
Feb 14, 2012	mccorkle douglas s	Officer	Sell	4,562	109.01 - 110.50
Nov 8, 2012	powchik peter	Officer	Sell	15,144	138.59 - 139.05
Nov 30, 2012	roberts william	Officer	Sell	11,500	177.43 - 186.00
Sep 22, 2008	roberts william	Officer	Sell	9,692	22.84
Aug 10, 2012	ryan arthur f	Director	Sell	10,000	136.15
Nov 1, 2012	ryan arthur f	Director	Sell	10,000	145.57
Jan 12, 2012	ryan arthur f	Director	Sell	25,500	78.86 - 79.09
May 31, 2013	ryan arthur f	Director	Sell	2,500	249.45 - 249.58
May 6, 2013	shooter eric m	Director	Sell	20,000	256.49 - 264.13
May 6, 2013	shooter eric m	Director	Sell	10,000	258.78 - 264.18
Feb 23, 2012	shooter eric m	Director	Sell	20,000	103.51 - 104.05
May 18, 2012	shooter eric m	Director	Sell	2,000	124.04
May 21, 2012	shooter eric m	Director	Sell	18,000	123.23 - 124.07
Feb 26, 2013	shooter eric m	Director	Sell	10,000	160.00
May 30, 2008	shooter eric m	Director	Sell	15,000	19.80 - 19.88
Oct 2, 2007	shooter eric m	Director	Sell	10,000	18.30 - 18.37
Nov 29, 2012	sing george l	Director	Sell	5,000	185.00
Nov 16, 2012	sing george l	Director	Sell	5,000	152.00
May 30, 2012	sing george l	Director	Sell	5,000	134.00
Showing 21-40 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.